Teva Pharma Industries Ltd ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $4,332,000 | $4,162,000 | $3,832,000 | $4,457,000 |
Gross Profit | 2,148,000 | 2,022,000 | 1,784,000 | 2,416,000 |
EBITDA | -51,000 | 1,073,000 | 928,000 | 1,451,000 |
EBIT | -310,000 | 814,000 | 656,000 | 1,185,000 |
Net Income | -437,000 | -845,000 | -139,000 | 429,000 |
Net Change In Cash | 4,332,000 | 4,162,000 | 3,832,000 | 4,457,000 |
Free Cash Flow | 545,000 | 323,000 | 47,000 | 1,065,000 |
Cash | 3,319,000 | 2,258,000 | 2,991,000 | 3,226,000 |
Basic Shares | 1,133,000 | 1,133,000 | 1,123,000 | 1,137,000 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $15,846,000 | $14,925,000 | $15,878,000 | $16,658,000 |
Gross Profit | 7,645,000 | 6,973,000 | 7,594,000 | 7,725,000 |
EBITDA | 433,000 | 4,105,000 | 4,528,000 | 4,610,000 |
EBIT | 433,000 | 2,797,000 | 3,198,000 | 3,053,000 |
Net Income | -559,000 | -2,353,000 | 417,000 | -3,990,000 |
Net Change In Cash | 15,846,000 | 14,925,000 | 15,878,000 | 16,658,000 |
Cost of Revenue | 149,000 | 194,000 | ||
Free Cash Flow | 842,000 | 1,042,000 | 236,000 | 638,000 |
Cash | 3,226,000 | 2,801,000 | 2,165,000 | 2,177,000 |
Basic Shares | 1,119,000 | 1,110,000 | 1,107,000 | 1,095,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.69 |
2024-06-30 | $0.61 |
2024-03-31 | $0.48 |
2023-12-31 | $1 |
